Amankwa et al., 2021 - Google Patents
Novel thiol containing hybrid antioxidant-nitric oxide donor small molecules for treatment of glaucomaAmankwa et al., 2021
View HTML- Document ID
- 11689687047263834205
- Author
- Amankwa C
- Gondi S
- Dibas A
- Weston C
- Funk A
- Nguyen T
- Nguyen K
- Ellis D
- Acharya S
- Publication year
- Publication venue
- Antioxidants
External Links
Snippet
Oxidative stress induced death and dysregulation of trabecular meshwork (TM) cells contribute to the increased intraocular pressure (IOP) in primary open angle (POAG) glaucoma patients. POAG is one of the major causes of irreversible vision loss worldwide …
- 208000010412 Glaucoma 0 title abstract description 23
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic, hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
-
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
- G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine, rifamycins
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0012—Galenical forms characterised by the site of application
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/48—Preparations in capsules, e.g. of gelatin, of chocolate
- A61K9/50—Microcapsules having a gas, liquid or semi-solid filling; Solid microparticles or pellets surrounded by a distinct coating layer, e.g. coated microspheres, coated drug crystals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
- A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
- A61K45/06—Mixtures of active ingredients without chemical characterisation, e.g. antiphlogistics and cardiaca
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Amankwa et al. | Novel thiol containing hybrid antioxidant-nitric oxide donor small molecules for treatment of glaucoma | |
Tóth et al. | Natural molecules and neuroprotection: kynurenic acid, pantethine and α-lipoic acid | |
Southam et al. | ‘Carbon-monoxide-releasing molecule-2 (CORM-2)’is a misnomer: ruthenium toxicity, not CO release, accounts for its antimicrobial effects | |
Ola et al. | Neurodegeneration and neuroprotection in diabetic retinopathy | |
Muangnoi et al. | Protective effects of curcumin ester prodrug, curcumin diethyl disuccinate against H2O2-induced oxidative stress in human retinal pigment epithelial cells: potential therapeutic avenues for age-related macular degeneration | |
Liu et al. | Salvianolic acid B (Sal B) protects retinal pigment epithelial cells from oxidative stress-induced cell death by activating glutaredoxin 1 (Grx1) | |
Milkovic et al. | Antioxidative 1, 4-dihydropyridine derivatives modulate oxidative stress and growth of human osteoblast-like cells in vitro | |
Gori | Exogenous NO therapy for the treatment and prevention of atherosclerosis | |
Li et al. | Hydrogen sulfide: novel endogenous and exogenous modulator of oxidative stress in retinal degeneration diseases | |
Rivera-Pérez et al. | Epigallocatechin 3-gallate has a neuroprotective effect in retinas of rabbits with ischemia/reperfusion through the activation of Nrf2/HO-1 | |
Montanari et al. | Intracellular delivery of natural antioxidants via hyaluronan nanohydrogels | |
Córdova-Delgado et al. | FRI-1 is an anti-cancer isoquinolinequinone that inhibits the mitochondrial bioenergetics and blocks metabolic shifts by redox disruption in breast cancer cells | |
Dal Monte et al. | Hypotensive effect of nanomicellar formulation of melatonin and agomelatine in a rat model: Significance for glaucoma therapy | |
Liu et al. | Proteomics reveals the potential protective mechanism of hydrogen sulfide on retinal ganglion cells in an ischemia/reperfusion injury animal model | |
Chiu et al. | Investigating therapeutic effects of indole derivatives targeting inflammation and oxidative stress in neurotoxin-induced cell and mouse models of Parkinson’s disease | |
Jekabsone et al. | The role of intracellular Ca2+ and mitochondrial ROS in small Aβ1-42 oligomer-induced microglial death | |
Pham et al. | Neuroprotection of rodent and human retinal ganglion cells in vitro/ex vivo by the hybrid small molecule SA-2 | |
Margari et al. | The encapsulation of citicoline within solid lipid nanoparticles enhances its capability to counteract the 6-hydroxydopamine-induced cytotoxicity in human neuroblastoma SH-SY5Y cells | |
Wang et al. | Antioxidant effects of quercetin nanocrystals in nanosuspension against hydrogen peroxide-induced oxidative stress in a zebrafish model | |
Wang et al. | Multiple-purpose connectivity map analysis reveals the benefits of esculetin to hyperuricemia and renal fibrosis | |
Han et al. | The application of nitric oxide for ocular hypertension treatment | |
Ricci et al. | Mechanisms of neuronal damage in acute hepatic porphyrias | |
Kosenko et al. | Is NMDA-receptor-mediated oxidative stress in mitochondria of peripheral tissues the essential factor in the pathogenesis of hepatic encephalopathy? | |
Amankwa et al. | Modulation of mitochondrial metabolic parameters and antioxidant enzymes in healthy and glaucomatous trabecular meshwork cells with hybrid small molecule SA-2 | |
Ghosh et al. | A novel NOX inhibitor treatment attenuates Parkinson’s disease-related pathology in mouse models |